Clin2
NCT07025642Possibly a fitRecruiting

Overactive Bladder Treatments for Women

Overactive Bladder (OAB)

Part of Kidney & urinary, Women’s health & pregnancy clinical trials.

This study compares different treatments for overactive bladder in women in Taiwan. It aims to find the best approach to help control symptoms like frequent or urgent urination.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
30 years to 100 years
Study type
Interventional

Who can take part

  • You are a woman.
  • You have been diagnosed with overactive bladder (feeling a sudden need to urinate often).
  • You do not have diabetes.
  • You have never had a stroke.
  • You do not have any other major medical problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07416968Recruiting· Phase 4
Low dose tadalafil vs solifenacin for overactive bladder in women

This study compares two medications—tadalafil (a daily pill for blood flow) and solifenacin (a pill that relaxes the bladder)—to see which works better for women with overactive bladder (OAB), which causes sudden, strong urges to urinate. It will help doctors find a treatment that may have fewer side effects.

Shibīn al Kawm, Al-Minūfiyyah
NCT07711808Not yet recruiting· Phase 4
Comparing Two Medicines for Overactive Bladder

This study compares two pills (solifenacin and mirabegron) for treating overactive bladder. It aims to see which works better and has fewer side effects. You may qualify if you're newly diagnosed and haven't tried these medicines before.

NCT07473310Recruiting· Phase 4
Shockwave therapy or solifenacin for overactive bladder in women

This trial compares a new treatment (low-intensity shockwave therapy) with a standard medication (solifenacin) to see which works better for women with overactive bladder (OAB). Overactive bladder means you feel a sudden, strong need to urinate, often have to go frequently, or may leak urine. The study aims to find a more effective or better-tolerated option.

Al Mansurah, Dakahlia Governorate
NCT07773532Not yet recruiting
Blood tests to predict bladder medication response in women

This trial tests whether simple blood tests can predict how well a woman with overactive bladder will respond to the medication mirabegron (also called Myrbetriq). If successful, doctors may be able to choose the right treatment earlier.

Istanbul, Bagcilar
NCT07553065Recruiting· Phase 2
Bladder Treatment Study with NT 201 and Vibe System

This study tests a new bladder treatment called NT 201 combined with a device called the Vibe System for women with overactive bladder (frequent, urgent need to urinate). The treatment is injected directly into the bladder and may help reduce urgency and leaking.

Reno, Nevada
NCT07025044Recruiting
Bladder microbiome study for women with overactive bladder getting Botox

This study looks at the bacteria in the bladders of women with overactive bladder who are getting Botox injections. It aims to understand how these bacteria might affect treatment results.

Washington D.C., District of Columbia

Hear when a new Overactive Bladder (OAB) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.